Joyce Liu, NP
Nurse Practitioner · South San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · County of San Mateo · 316 clinicians in this group
Looking this up.
Hospitals listed: San Mateo Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Joyce Liu’s office at (650) 573-2222 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Medicaid work
$25,759 in 2024
Medicaid paid $25,759 for 1,375 billed services this clinician did in 2024, up to 75 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 534 | $11,808 |
| Short return visit (20+ min) | 491 | $7,968 |
| Screening for depression is documented as negative, a follow-up plan is not required | 252 | $4,154 |
| Sign language or oral interpretive services, per 15 minutes | 85 | $1,778 |
| Short return visit | 13 | $52 |
| 2024 | 1,375 | 5 | 75 | $25,759 |
| 2023 | 1,522 | 6 | 86 | $16,190 |
| 2022 | 1,609 | 4 | 79 | $18,857 |
| 2021 | 339 | 4 | 66 | $2,041 |
See the largest Medicaid services in earlier years
2023
| Sign language or oral interpretive services, per 15 minutes | 362 | $6,440 |
| Short return visit (20+ min) | 730 | $4,378 |
| Screening for depression is documented as negative, a follow-up plan is not required | 186 | $2,458 |
| Return visit (30+ min) | 191 | $1,747 |
| New patient visit (30+ min) | 34 | $1,055 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 19 | $112 |
2022
| Short return visit (20+ min) | 879 | $7,062 |
| Sign language or oral interpretive services, per 15 minutes | 407 | $7,020 |
| Screening for depression is documented as negative, a follow-up plan is not required | 227 | $2,856 |
| New patient visit (30+ min) | 96 | $1,919 |
2021
| Sign language or oral interpretive services, per 15 minutes | 54 | $866 |
| Short return visit (20+ min) | 213 | $635 |
| Screening for depression is documented as negative, a follow-up plan is not required | 60 | $540 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 12 | $0 |
Drugs they prescribed that Part D paid
$307,041
Pharmacies billed $307,041 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (15 of 2,040) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,586 generic and 399 brand-name prescriptions · $307,041 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 69 | $75,818 | $1,099 |
| Trulicity | 34 | $37,899 | $1,115 |
| Eliquis | 23 | $23,000 | $1,000 |
| Januvia | 23 | $20,019 | $870 |
| Basaglar Kwikpen U-100 | 25 | $11,243 | $450 |
See all 47 drugs
| Jardiance | 69 | $75,818 | $1,099 |
| Trulicity | 34 | $37,899 | $1,115 |
| Eliquis | 23 | $23,000 | $1,000 |
| Januvia | 23 | $20,019 | $870 |
| Basaglar Kwikpen U-100 | 25 | $11,243 | $450 |
| Victoza 3-Pak | 12 | $9,050 | $754 |
| Liraglutide | 13 | $8,701 | $669 |
| Insulin Glargine-Yfgn | 43 | $5,002 | $116 |
| Albuterol Sulfate Hfa | 99 | $4,762 | $48 |
| Atorvastatin | 114 | $1,821 | $16 |
| Quetiapine | 15 | $1,719 | $115 |
| Lantus Solostar | 13 | $1,311 | $101 |
| Sertraline | 27 | $937 | $35 |
| Trueplus Pen Needle | 19 | $922 | $49 |
| Fluticasone Propionate | 73 | $898 | $12 |
| Metformin | 89 | $893 | $10 |
| Levothyroxine | 56 | $733 | $13 |
| Gabapentin | 54 | $724 | $13 |
| Gemfibrozil | 12 | $694 | $58 |
| Pantoprazole | 40 | $662 | $17 |
| Tamsulosin | 32 | $619 | $19 |
| Losartan | 68 | $536 | $8 |
| Famotidine | 41 | $514 | $13 |
| Celecoxib | 24 | $464 | $19 |
| Amlodipine Besylate | 114 | $438 | $4 |
| Lovastatin | 12 | $362 | $30 |
| Fenofibrate | 12 | $352 | $29 |
| Cyclobenzaprine | 12 | $293 | $24 |
| Lisinopril | 59 | $265 | $4 |
| Omeprazole | 15 | $263 | $18 |
| Simvastatin | 16 | $248 | $15 |
| Triamcinolone Acetonide | 26 | $246 | $9 |
| Metoprolol | 24 | $236 | $10 |
| Glipizide | 44 | $228 | $5 |
| Alendronate | 31 | $217 | $7 |
| Allopurinol | 16 | $187 | $12 |
| Ezetimibe | 18 | $169 | $9 |
| Ketoconazole | 11 | $123 | $11 |
| Ibuprofen | 31 | $120 | $4 |
| Fenofibrate | 14 | $115 | $8 |
| Clopidogrel | 12 | $104 | $9 |
| Metformin Hcl Er | 17 | $94 | $6 |
| Hydrochlorothiazide | 36 | $83 | $2 |
| Carvedilol | 24 | $78 | $3 |
| Furosemide | 18 | $73 | $4 |
| Rosuvastatin | 11 | $71 | $6 |
| Trazodone | 16 | $56 | $4 |
Year by year
| 2024 | 2,040 | 136 | 1% (15) | 20% | $307,041 |
| 2023 | 1,828 | 119 | 1% (17) | 19% | $350,030 |
| 2022 | 1,396 | 128 | None | 21% | $221,403 |
| 2021 | 145 | 70 | 0% (0) | 14% | $13,557 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Jardiance | 52 | $83,695 | $1,610 |
| Xifaxan | 12 | $41,752 | $3,479 |
| Trulicity | 27 | $32,526 | $1,205 |
| Eliquis | 22 | $26,654 | $1,212 |
| Januvia | 22 | $25,734 | $1,170 |
| Victoza 3-Pak | 16 | $17,678 | $1,105 |
| Basaglar Kwikpen U-100 | 24 | $13,575 | $566 |
| Tradjenta | 11 | $11,893 | $1,081 |
| Insulin Glargine-Yfgn | 36 | $6,483 | $180 |
| Breo Ellipta | 15 | $6,483 | $432 |
| Atorvastatin | 125 | $4,079 | $33 |
| Albuterol Sulfate Hfa | 44 | $3,054 | $69 |
| Amlodipine Besylate | 122 | $2,049 | $17 |
| Tretinoin | 11 | $1,785 | $162 |
| Metformin | 92 | $1,758 | $19 |
| Quetiapine | 11 | $1,412 | $128 |
| Losartan | 66 | $1,401 | $21 |
| Gabapentin | 44 | $1,353 | $31 |
| Fluticasone Propionate | 71 | $1,294 | $18 |
| Levothyroxine | 48 | $1,159 | $24 |
| Lisinopril | 59 | $975 | $17 |
| Famotidine | 44 | $926 | $21 |
| Sertraline | 25 | $888 | $36 |
| Tamsulosin | 32 | $843 | $26 |
| Pantoprazole | 30 | $743 | $25 |
| Omeprazole | 28 | $743 | $27 |
| Ezetimibe | 14 | $640 | $46 |
| Metoprolol | 21 | $636 | $30 |
| Gemfibrozil | 11 | $634 | $58 |
| Trueplus Pen Needle | 26 | $519 | $20 |
| Glipizide | 43 | $492 | $11 |
| Allopurinol | 19 | $483 | $25 |
| Clopidogrel | 16 | $423 | $26 |
| Simvastatin | 23 | $420 | $18 |
| Alendronate | 18 | $402 | $22 |
| Metformin Hcl Er | 11 | $394 | $36 |
| Ketoconazole | 16 | $311 | $19 |
| Furosemide | 30 | $308 | $10 |
| Metoprolol | 12 | $276 | $23 |
| Lovastatin | 13 | $235 | $18 |
| Triamcinolone Acetonide | 14 | $220 | $16 |
| Carvedilol | 20 | $191 | $10 |
| Fenofibrate | 11 | $155 | $14 |
| Diclofenac | 13 | $140 | $11 |
| Baclofen | 11 | $128 | $12 |
| Hydrochlorothiazide | 22 | $119 | $5 |
2022: 37 drugs
| Jardiance | 39 | $39,331 | $1,008 |
| Trulicity | 25 | $26,852 | $1,074 |
| Lantus Solostar | 38 | $17,343 | $456 |
| Tradjenta | 25 | $14,248 | $570 |
| Januvia | 19 | $13,907 | $732 |
| Eliquis | 19 | $13,353 | $703 |
| Victoza 3-Pak | 11 | $11,500 | $1,045 |
| Albuterol Sulfate Hfa | 52 | $2,698 | $52 |
| Atorvastatin | 81 | $1,961 | $24 |
| Quetiapine | 11 | $1,424 | $129 |
| Metformin | 70 | $1,154 | $16 |
| Losartan | 61 | $1,134 | $19 |
| Sertraline | 29 | $1,057 | $36 |
| Amlodipine Besylate | 95 | $988 | $10 |
| Levothyroxine | 36 | $791 | $22 |
| Famotidine | 41 | $663 | $16 |
| Lisinopril | 53 | $663 | $13 |
| Simvastatin | 24 | $622 | $26 |
| Pravastatin | 19 | $608 | $32 |
| Pantoprazole | 32 | $572 | $18 |
| Metoprolol | 19 | $509 | $27 |
| Fluticasone Propionate | 39 | $496 | $13 |
| Omeprazole | 27 | $488 | $18 |
| Tamsulosin | 15 | $397 | $26 |
| Alendronate | 17 | $369 | $22 |
| Trueplus Pen Needle | 13 | $326 | $25 |
| Lovastatin | 21 | $318 | $15 |
| Glipizide | 28 | $272 | $10 |
| Spironolactone | 13 | $258 | $20 |
| Gabapentin | 17 | $221 | $13 |
| Metoprolol | 12 | $205 | $17 |
| Clopidogrel | 13 | $202 | $16 |
| Carvedilol | 15 | $133 | $9 |
| Celecoxib | 11 | $121 | $11 |
| Furosemide | 15 | $76 | $5 |
| Hydrochlorothiazide | 16 | $70 | $4 |
| Cyclobenzaprine | 13 | $17 | $1 |
2021: 2 drugs
| Amlodipine Besylate | 12 | $112 | $9 |
| Metformin | 11 | $76 | $7 |
Money from drug and device companies
$20 in 2024
A payment is not proof that care is biased.
| ConvaTec | Convatec Inc. | $20 | 1 payment
|
See the published payment
| ConvaTec | Meals · 2024-02-27 | Convatec Inc. | $20 |
Professional record
- NPI
- 1386295657
- Licence
- CA 95012941
- Group
- County of San Mateo
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 576 E El Camino Real, Sunnyvale, CA, 94087
- NPI first listed
- 2019-09-26
- NPI last updated
- 2019-11-12
This is when the NPI record was last certified, not a medical board exam.